{"Title": ["3 Healthcare Stocks That Surged Last Week", "Here's Why Celldex Therapeutics Stock Is Soaring Today", "FDA Nod For JAZZ's Drug, BYSI's PROTECTIVE-2 Trial Meets Goals, EDSA To Begin COVID-19 Drug Trial", "Health Care Sector Update for 06/08/2020: OPNT, TEVA, CLDX, SRPT, XLV, IBB", "Financial Sector Update for 11/13/2019: BPY,JPM,CLDX,KNSL,NNI", "Today's Top 6 Gainers In Healthcare Sector (AGRX, BNTX, SIBN...)", "Celldex Therapeutics Inc (CLDX) Q2 2019 Earnings Call Transcript", "Celldex Therapeutics Keeps Up Its Penny-Pinching and Pipeline Progress", "3 Healthcare Stocks That Surged Last Week", "7 Top Gainers In Healthcare Sector (PHAS, MLNT, TTOO...)", "Is Celldex Therapeutics (CLDX) Stock Outpacing Its Medical Peers This Year?", "Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat", "Celldex Therapeutics' Cost-Cutting and Reverse Stock Split Help Keep It Rolling", "Celldex Therapeutics, Inc (CLDX) Q4 2018 Earnings Conference Call Transcript", "Earnings Reaction History: CELLDEX THERAPT, 100.0% Follow-Through Indicator, 4.4% Sensitive", "Celldex Therapeutics (CLDX) Stock Sinks As Market Gains: What You Should Know", "EARNINGS SUMMARY: Details of Celldex Therapeutics Inc. Q2 Earnings Report", "5 Tiny Biotech Stocks With Superb Growth Potential", "Here's Why Celldex Therapeutics Sank on Friday", "Why Celldex Therapeutics Is Jumping Today", "Why Is Celldex (CLDX) Down 29% Since Last Earnings Report?", "Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss", "Celldex Therapeutics Inc. Chugs Along in the 3rd Quarter Despite Challenges", "Here's Why Celldex Therapeutics, Inc. Surged on Thursday", "The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna", "5 Tiny Biotech Stocks With Superb Growth Potential", "Here's Why Celldex Therapeutics Sank on Friday", "Why Celldex Therapeutics Inc. Shares Jumped on Wednesday", "Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates", "Celldex Therapeutics, Inc. Spending Cuts Help Preserve Cash in the 2nd Quarter", "Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates", "Celldex Therapeutics (CLDX) Reports Q3 Loss, Lags Revenue Estimates", "How David Gardner's Biggest Losers Demonstrate Why Long-Term Investing Wins", "Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics", "Celldex Therapeutics (CLDX) Down 9.2% Since Earnings Report: Can It Rebound?", "Celldex (CLDX) Q1 Loss Wider Than Expected, Shares Down", "Celldex (CLDX) Q1 Loss Narrower, Revenues Beat, Shares Down", "Celldex Therapeutics Moves Forward After Glemba Clinical Failure", "What's in Store for Celldex (CLDX) This Earnings Season?", "What's in Store for Celldex (CLDX) This Earnings Season?", "Is It Game Over for Celldex?", "Johnson & Johnson's First-Quarter 2018 Earnings Review", "Biotech Stock Roundup: ALKS Up, CLDX Down, ALXN to Acquire Wilson Therapeutics", "Celldex's Phase II Breast Cancer Study Fails, Shares Plunge", "Mid-Day Market Update: Crude Oil Down Over 1%; Eldorado Resorts Shares Surge", "Mid-Morning Market Update: Markets Open Higher; Bank of America Earnings Top Estimates", "Health Care Sector Update for 04/16/2018: ALKS, CLDX, APRI", "Lessons to Learn From April's Biotech Blowups", "Health Care Sector Update for 04/16/2018: SHPS,CLDX,ALKS,APRI", "Mid-Afternoon Market Update: Dow Rises 300 Points; Apricus Biosciences Shares Plummet", "Health Care Sector Update for 04/16/2018: CLDX,ALKS,APRI", "Monday Sector Laggards: Drugs, Agriculture & Farm Products", "Implied Volatility Surging for Celldex Therapeutics (CLDX) Stock Options", "3 Top Small-Cap Biotech Stocks for Aggressive Investors", "Why Celldex Therapeutics Stock Crashed in February", "Why Celldex Therapeutics Stock Is Cratering Today", "3 Top Healthcare Stocks to Buy in March", "Celldex Therapeutics: Make-or-Break-It Data Expected Soon", "Celldex (CLDX) Q4 Loss Narrows, Revenues Beat, Shares Up", "Celldex Therapeutics Finishes 2017 With Plenty of Cash and High Hopes", "Why Celldex Therapeutics Shot Up Today", "AVEO Pharmaceuticals' (AVEO) Q4 Earnings: What's in Store?", "What's in the Cards for Merck KGaA (MKGAF) in Q4 Earnings?", "Is Celldex Therapeutics Stock About to Skyrocket?", "Is a Beat in the Cards for Celldex (CLDX) in Q4 Earnings?", "3 Stocks That Could Put Tesla's Returns to Shame", "Is Celldex Therapeutics, Inc. (CLDX) a Buy?", "3 Growth Stocks That Could Put Shopify's Returns to Shame", "Will 2018 Be Celldex Therapeutics, Inc.'s Best Year Yet?", "Amgen Announces Acceptance of MAA for Evenity in Europe", "AbbVie's Upadacitinib Gains Breakthrough Therapy Designation", "What's in Store for Catalyst (CPRX) This Earnings Season?", "3 Biotech Stocks to Buy in January", "4 Reasons to Include Celldex (CLDX) Stock in Your Portfolio", "TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise", "AbbVie's RA Candidate Meets Endpoints in 3rd Phase III Study", "Minerva Initiates Phase III Study on Schizophrenia Candidate", "TherapeuticsMD Falls Despite Acceptance of NDA: Here's Why", "Shire's New Formulation of Oncaspar Gets Approval in Europe", "Ultragenyx Announces Interim Data from Early Stage Study", "Why Celldex Therapeutics Stock Reversed Course in November", "Cancer Space Update: Pfizer's Bavencio Fails in Phase III", "Celldex Begins Phase I Trial on Cancer Candidate CDX-1140", "Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.", "Here's Where Things Went Wrong for Celldex Therapeutics, Inc. in 2017", "Celldex (CLDX) Initiates Phase II Study on Cancer Candidate", "Celldex (CLDX) Q3 Loss Narrows, Revenues Beat, Shares Up", "Glaxo's Nucala Label Expansion Application Gets FDA Approval", "Why Celldex Therapeutics Stock Reversed Course in November", "Cancer Space Update: Pfizer's Bavencio Fails in Phase III", "Celldex Begins Phase I Trial on Cancer Candidate CDX-1140", "Celldex (CLDX) to Report Q3 Earnings: What's in the Cards?", "Mid-Afternoon Market Update: Crude Oil Up Over 1%; Polaris Shares Surge On Upbeat Earnings", "10 Stunning Numbers You Need to Know About Breast Cancer", "Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics", "How to Invest in Biotech Stocks", "Why Celldex Therapeutics, Inc. Jumped Higher Today", "3 Small-Cap Biotech Stocks to Buy This Fall", "3 Top Healthcare Stocks to Buy Now", "Celldex Ends Phase II Enrollment for Breast Cancer Candidate", "3 Top Biotech Stocks Under $10", "3 Beaten-Up Biotech Stocks: Are They Bargains?", "Celldex (CLDX) Q2 Loss Narrows, Revenues Beat, Shares Up", "What's Behind Celldex Therapeutics, Inc.'s 16% Rally in September?", "What's in the Cards for Celldex (CLDX) this Earnings Season?", "Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics", "Down 14.8%: Is Celldex Therapeutics Stock an Incredible Bargain?", "3 Stocks That Could Double Your Money", "3 Stocks with Universal Display-like Return Potential", "Why Is Celldex (CLDX) Down 27% Since the Last Earnings Report?", "3 Beaten-Up Biotech Stocks: Are They Bargains?", "Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum", "Here's Why Celldex Therapeutics, Inc. Fell Today", "Here's What Shaved 14% Off Celldex Therapeutics, Inc.'s Stock Price in May", "Celldex Therapeutics, Inc.: The Bear Case from a Bull", "Celldex's Immuno-Oncology Pipeline Continues to Impress", "Better Buy: Celldex Therapeutics, Inc. vs. Agenus Inc.", "3 Value Stocks for Bold Investors", "Celldex (CLDX) Q1 Loss In Line, Revenues Beat, Shares Up", "3 Stocks That Look Just Like Oracle in 1986", "Celldex Therapeutics, Inc.'s Collaboration with Bristol-Myers Squibb Key in First-Quarter Update", "Celldex Therapeutics (CLDX) Q1 Earnings: What's in Store?", "Meditor Group Ltd Buys Celldex Therapeutics, Sells VIVUS", "Read This Before You Buy Biotech Stocks", "What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings?", "Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?", "Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?", "3 Stocks That Could Double Your Investment", "Why Is Celldex (CLDX) Down 4.4% Since the Last Earnings Report?", "3 Cancer Drug Stocks That Could Make You Rich", "3 Biotech Stocks to Buy on Sale", "3 Stocks That Could Double Your Money", "3 Top Stocks You've Been Overlooking", "3 Stocks That Could Double Your Money", "Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat", "What's in Store for Biogen (BIIB) this Earnings Season?", "After-Hours Earnings Report for March 14, 2017 : HTHT, AKAO, CLDX, FOGO, NPTN, ARNA, CCXI, KURA, DRRX, CHMI, CNXR", "3 Horrible Stocks for Retirees", "Better Buy: Agenus Inc. vs. Celldex Therapeutics", "Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat", "Celldex Therapeutics, Inc. Is Feeling Some Pressure Today -- Here's Why", "Why Celldex Therapeutics Stock Gained 10% in February", "Celldex Therapeutics (CLDX) Q4 Earnings: What's in Store?", "Celldex Therapeutics, Inc. Ends Q4 With Plenty of Cash and Several Key Studies Progressing", "Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics Inc", "3 Biotech Long Shots: Boom Or Bust?", "Looking Back at David Gardner's Worst Stock Picks of the Past 3 Years", "Why Celldex Therapeutics Stock Fell by Almost 10% in January", "3 Stocks That Could Make You Rich", "3 Biotech Stocks I'd Buy Right Now", "5 Small-Cap Biotech Stocks to Buy in February", "3 Stocks That Could Double Your Money", "Why Celldex Therapeutics Imploded in 2016", "Celldex Therapeutics, Inc.'s 3 Best Moves in 2016", "Better Buy: Celldex Therapeutics, Inc. vs. Exelixis", "2016's Worst Clinical Failures", "How to Value Clinical-Stage Biotech Stocks", "Celldex Therapeutics, Inc.'s Biggest Failure in 2016", "3 Cheap Healthcare Stocks You Can Buy Right Now", "3 Beaten-Down Biotech Stocks You Can Buy Right Now", "Why Celldex Rallied 22% In November", "Why You Should (and Shouldn't) Buy Celldex Therapeutics, Inc.", "Down 11.7%: Is Celldex Therapeutics Now a Buy?", "Mid-Afternoon Market Update: Fang Holdings Drops Following Q3 Results; Recro Pharma Shares Surge", "Ready to Get In on Biotech? Check Out These 3 Stocks", "Celldex Stock Up on Positive Data on New Cancer Candidate", "Why Celldex Therapeutics, Inc. Stock Jumped Higher Again Today", "Is Celldex Therapeutics (CLDX) Stock a Solid Choice Right Now?", "Celldex (CLDX) Q3 Loss Narrower than Expected, Sales Beat", "Why Celldex Therapeutics, Inc. Jumped Higher Today", "Celldex Therapeutics, Inc. Watches Its Cash in Q3, Ready to Expand", "3 Biotech Stocks That Could Double in 12 Months", "Celldex (CLDX): Will the Stock Surprise in Q3 Earnings?", "Better Buy: Celldex Therapeutics, Inc. vs. bluebird bio, Inc.", "Better Buy: NantKwest, Inc. vs. Celldex Therapeutics, Inc.", "Why Celldex Therapeutics, Inc. Stock Tumbled 22% in October", "Celldex (CLDX) Q3 Loss Narrower than Expected, Sales Beat", "Why Celldex Therapeutics, Inc. Jumped Higher Today", "Celldex Therapeutics, Inc. Watches Its Cash in Q3, Ready to Expand", "Mid-Afternoon Market Update: Dow Drops More Than 100 Points; Summit Therapeutics Shares Spike Higher", "Why Celldex Therapeutics, Inc. Jumped Higher Today", "Forget Celldex Therapeutics, Inc.: These 2 Stocks Doubled Last Year", "10 Biotech Stocks to Put on Your Radar This Quarter", "Is This Risky Biotech Stock About to Jump Higher?", "These 3 Little Biotechs Just Scored Big", "3 Beaten-Up Healthcare Stocks: Are They Bargains?", "We Did The Math XBI Can Go To $83", "How Risky Is Celldex Therapeutics, Inc.?", "Celldex Therapeutics, Inc.'s Q2 Results Hint at Another Stock Offering", "Celldex (CLDX) Posts Narrower Q2 Loss, Focus on Pipeline", "Why Celldex Therapeutics, Inc. Ran Higher Today", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. Celldex Therapeutics", "3 Biotech Stocks That Could Soar Over the Next 12 Months", "5 Things Celldex Therapeutics, Inc. Wants You to Know", "3 Shocking Biotech Flops of 2016 So Far", "These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains", "4 Cancer Drug Developers You Need to Have on Your Radar This Year", "Celldex (CLDX) Presents Phase II Melanoma Study Data", "Celldex (CLDX): What's Ahead for the Stock in Q2 Earnings?", "The 10 Best Healthcare Stocks to Buy Now", "3 Reasons Celldex Therapeutics Stock Could Rise", "Mid-Afternoon Market Update: Crude Oil Down Over 2.5%; Horizon Pharma Shares Rise Following Earnings Beat", "Celldex (CLDX) Posts Wider Q1 Loss, Focus on Pipeline", "Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More", "Celldex (CLDX): What's Ahead for the Stock in Q1 Earnings?", "5 Billionaires Just Bought 3.3 Million Shares of Celldex Therapeutics", "Better Buy: Celldex Therapeutics, Inc. vs. Ionis Pharmaceuticals, Inc.", "The 10 Best Healthcare Stocks to Buy Now", "3 Reasons Celldex Therapeutics Stock Could Rise", "Mid-Afternoon Market Update: Crude Oil Down Over 2.5%; Horizon Pharma Shares Rise Following Earnings Beat", "Celldex (CLDX) Posts Wider Q1 Loss, Focus on Pipeline", "Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More", "Why Celldex Therapeutics, Inc. Stock Sank 50% in March", "This One Drug Alone Makes Celldex Therapeutics, Inc. a Buy (Hint: It's not Rintega)", "Health Care Sector Update for 04/27/2016: CLDX, OASM", "Why Galena Biopharma Inc PRESENTed a Higher Stock Price", "Celldex Therapeutics, Inc. Bounces Higher", "What Celldex Therapeutics, Inc.'s Failure Teaches Biotech Investors About Risk", "What Rintega's Clinical Trial Flop Means for Celldex Therapeutics' Future", "3 Big Risks Biotech Stocks Face", "The Zacks Analyst Blog Highlights: AbbVie, Vertex, Celldex and Celgene", "Celldex Therapeutics, Inc. Sure Loves Mondays", "Celldex Advised to Discontinue Phase III Study on Rintega", "Mid-Day Market Update: US Stocks Turn Higher; COMSCORE Shares Drop", "Downgrades: 3 Things You Must Know About the Crash at Celldex Therapeutics", "Why Celldex Therapeutics (CLDX) is Down Big Today", "Celldex Therapeutics' Stock Is Getting Crushed Today -- Here's Why", "US Markets Set to Open Lower Despite Oil Gains", "US Futures Take a Breather After Last Week's Rally; Oil Gains", "Health Care Sector Update for 03/08/2016: CLDX, XBIT", "Mid-Afternoon Market Update: Crude Oil Up 5%; Pier 1 Imports Shares Spike Higher", "Waiting on Celldex Therapeutics, Inc.", "Why Celldex Therapeutics, Inc. and bluebird bio, Inc. Jumped Today", "Why Celldex Therapeutics and Momenta Pharmaceuticals Traded Down Today", "Celldex's Q4 Loss Narrower than Expected; Focus on Pipeline", "Celldex's (CLDX) Q4 Loss a Penny Narrower than Expected", "6 Stocks to Buy Now for Battered Bargains", "Monday's ETF with Unusual Volume: ITOT", "Health Care Sector Update for 02/22/2016: CLDX, VCEL", "Here's Why Celldex Therapeutics Got Crushed in January", "Why Did Biotech Fall Off a Cliff in January?", "Celldex Therapeutics, Inc. Slips Some More", "Celldex Therapeutics, Inc. Gets Rocked as Data Approaches", "3 Biotech Stocks With Jaw-Dropping Growth Potential in 2016", "After Hours Most Active for Jan 15, 2016 : EXR, MSCC, DYAX, BAC, NKTR, ATW, EPR, NBIX, CLDX, NVAX, BX, HPE", "What's in Store for Celldex (CLDX) This Earnings Season?", "Health Care Sector Update for 02/22/2016: CLDX, VCEL", "Here's Why Celldex Therapeutics Got Crushed in January", "Why Did Biotech Fall Off a Cliff in January?", "Will Celldex (CLDX) Continue to Surge Higher?", "Celldex Therapeutics (CLDX) in Focus: Stock Rises 11.9%", "Celldex Jumps on Phase II Overall Survival Data on Rintega", "Why Shares in Celldex Therapeutics Dropped 10% Today", "Monday's ETF Movers: XBI, ILF", "Why Celldex Therapeutics Shares Jumped Today", "Why Celldex Therapeutics, Inc. Is Up for a Second Straight Day", "Monday's ETF Movers: XBI, RWX", "Celldex Therapeutics, Inc. Earnings: Waiting to ACT", "Celldex's Q3 Loss Narrower than Expected; Focus on Pipeline", "Why Celldex Therapeutics, Inc. Bounded Higher Today", "Celldex Therapeutics Shares Are Surging Higher", "Monday's ETF Movers: XBI, ILF", "After Hours Most Active for Oct 16, 2015 : PDLI, DYAX, NVAX, CLDX, QQQ, JUNO, GE, ECA, PBR, PFE, CPPL, BAC", "The Zacks Analyst Blog Highlights: Juno Therapeutics, Kite Pharma, Merck, Bristol-Myers Squibb and Celldex Therapeutics", "Breaking Down Biotech's Bloodbath: Which Companies to Buy", "5 Stocks Searching for a Cancer Cure Right Now", "Why Celldex Shares Jumped 12% Friday", "5 Top Stocks to Buy in October", "Can Celldex (CLDX) Surprise Estimates in Q3 Earnings?", "Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session", "Why Shares of Celldex Therapeutics, Inc. Soared on Tuesday", "3 Top Small-Cap Biotech Stocks to Buy Right Now", "Here's Why Celldex Therapeutics' Stock Got Crushed Today", "Celldex Q2 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog", "3 Key Things to Know About Celldex Therapeutics, Inc.'s Q2 Results", "Health Care Sector Update for 08/11/2015: CLDX, KERX, RPTP", "Is Celldex a Bargain After Losing a Third of Its Value Last Month?", "Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session", "Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog", "These 3 Biotech Stocks Are Losing Money, But We'd Still Buy Them", "This Terrifying Cancer May Finally Be Treatable", "Celldex Glioblastoma Vaccine Hits Phase II Primary Endpoint - Analyst Blog", "3 Best of Breed Biotech Stocks", "RSI Alert: Celldex Therapeutics (CLDX) Now Oversold", "3 Stock Market Tips for the Biotech Industry", "Use Options For a Chance To Buy CLDX at a 47% Discount", "3 Tiny Healthcare Stocks You Ought to Be Watching", "Celldex Therapeutics, Inc. Off to a Good Start in 2015", "Celldex 1Q Loss Narrower-Than-Expected, Pipeline in Focus - Analyst Blog", "Notable ETF Inflow Detected - FBT, ICPT, PCYC, CLDX", "Health Care Sector Update for 04/20/2015: CLDX, LGND, LLY", "First Week of CLDX July 17th Options Trading", "Celldex Initiates Study on Varlilumab for Metastatic Melanoma - Analyst Blog", "Disruptive Innovation Changing the Fight Against Cancer", "Use Options For a Chance To Buy CLDX at a 44% Discount", "3 Up and Coming Biotech Stocks to Watch", "Celldex, Roche Ink Deal to Develop Kidney Cancer Drug - Analyst Blog", "Health Care Sector Update for 03/17/2015: CLDX, BMRN, ICPT", "Bristol-Myers' Drug Shows Impressive Data, Inks Deal - Analyst Blog", "Exelixis' Cometriq Gets Fast Track Status in U.S. - Analyst Blog", "Wednesday's ETF Movers: XBI, ILF", "Use Options For a Chance To Buy CLDX at a 53% Discount", "Pre-Market Most Active for Feb 26, 2015 : ELX, BAC, RIG, AAPL, CRM, AMT, PVA, CYBX, CLDX, TVIX, GOGO, FB", "Celldex Therapeutics Inc. Q4 Earnings Overshadowed by FDA News", "Celldex Therapeutics (CLDX) Wider-than-Expected Loss in Q4 - Tale of the Tape", "Health Care Sector Update for 02/23/2015: RIGL, CLDX, GEVA", "Will Celldex Therapeutics (CLDX) Disappoint This Earnings? - Analyst Blog", "Why Celldex Therapeutics, Inc. Is Soaring", "Why Shares of Celldex Therapeutics Inc. Skyrocketed Today", "Monday Sector Leaders: Drugs, Biotechnology Stocks", "Celldex/Bristol-Myers Initiate Phase I/II Solid Tumor Study - Analyst Blog", "Commit To Purchase Celldex Therapeutics At $18, Earn 16.9% Annualized Using Options", "Celldex Therapeutics (CLDX) Jumps: Stock Moves Up 8.9% - Tale of the Tape", "After Hours Most Active for Jan 16, 2015 : NVAX, CLDX, FXCM, T, PBR, PDLI, AMAT, VTR, WFC, SPLS, BAC, CMCSA", "3 Beaten Down Stocks Ready to Bounce Back", "Health Care Sector Update for 02/23/2015: CLDX,RIGL,SPPI", "Why Shares of Celldex Therapeutics Inc. Skyrocketed Today", "Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog", "Mid-Morning Market Update: Markets Edge Lower; Halliburton To Acquire Baker Hughes For $34.6 Billion", "Health Care Sector Update for 11/17/2014: ACT,AGN,DRTX,VRX,VRX.TO", "Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog", "CLDX Crosses Above Key Moving Average Level", "3 Beaten Down Biotech Stocks to Buy Now", "Celldex's Glembatumumab Vedotin in Phase II for Melanoma - Analyst Blog", "Celldex Therapeutics, Inc. (CLDX) in Focus: Stock Soars 28.9% - Tale of the Tape", "Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog", "Celldex Therapeutics (CLDX) Soars: Stock Adds 12.6% in Session - Tale of the Tape", "Thursday's ETF Movers: XBI, EWD", "Oncothyreon Collaborates with Celldex - Analyst Blog", "Healthcare Stocks Climbing in Late Trade; Celldex, Oncothyreon Partnering on Prospective Cancer Treatment", "Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog", "Why You Shouldn't Bet Against Celldex Therapeutics (CLDX) Stock - Tale of the Tape", "Tuesday's ETF Movers: XBI, GDXJ", "Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog", "Celldex Therapeutics (CLDX) Soars: Stock Adds 26.9% in Session - Tale of the Tape", "Celldex Gains on Bristol-Myers Squibb Deal - Analyst Blog", "Mid-Afternoon Market Update: Markets Head Downward As Commodities Continue To Show Strength", "Friday's ETF Movers: XBI, GDXJ", "Sector Update: Healthcare", "Sector Update: Healthcare Shares Lower Pre-Market; Mylan Q1 Earnings Top Street View", "Sector Update: Healthcare", "Encouraging Pre-Clinical Data from Celldex - Analyst Blog", "Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After AIC China Review Update", "Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 Profit", "Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness", "Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog", "Celldex's Q1 Loss Widens - Analyst Blog", "Broad-Based Declines for Healthcare Stocks; Celldex Down 11% After Q4 Net Loss Widens, Revenue Falls 83%", "Sector Update: Healthcare", "Pre-Market Earnings Report for March 3, 2014 : MGA, SSYS, ROC, NUS, PGH, AKRX, CLDX, RBA, EVEP, MGLN, SWC, SSW", "Interesting CLDX Put And Call Options For April 19th", "Agenus: Acquisition Of 4-Antibody Is A Transformational Move", "Celldex: Some Thoughts On Rindopepimut", "Pre-Market Most Active for Dec 5, 2013 : NOK, GTAT, AAPL, FB, BAC, SOL, AEG, CLDX, DRYS, QQQ, ALU, CCL", "Celldex Therapeutics (CLDX) in Focus: Stock Tumbles 10.1% - Tale of the Tape", "Broad-Based Declines for Healthcare Stocks; Celldex Down 11% After Q4 Net Loss Widens, Revenue Falls 83%", "Sector Update: Healthcare", "Mid-Afternoon Market Update: Twitter IPO a Wild Success as Markets Slide", "Celldex: What's All The Excitement About?", "Agenus: Thoughts On Phase II Results For Prophage In Glioblastoma", "These ETFs House The Next Biotech Takeover Targets", "Mid-Morning Market Update: Markets Edge Higher; Wal-Mart Names New CEO", "Mid-Day Market Update: Sysco Drops On Q4 Results, McEwen Mining Shares Rise", "Mid-Morning Market Update: US Markets Mixed, BlackBerry To Explore Strategic Alternatives", "Biotech Stocks: Breast Cancer Drugs in Clinical Trials Offer New Hope", "Market Wrap for July 5: Stocks, Oil, U.S. Dollar Jump in Wake of Strong Payrolls Report; Treasuries and Precious Metals Plunge", "Market Wrap for Tuesday, July 2: Stocks Close Near Unchanged Mark in Quiet Session", "Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs", "CLDX up 223%, Cohen Gains Big", "Agenus: Upcoming MAGE A-3 Clinical Trial Results Will Have A Major Impact On The Stock", "Encouraging Data Presented by Gilead - Analyst Blog", "Pharmacyclics to Sell Shares - Analyst Blog", "Santarus Tops, Focus on Zegerid - Analyst Blog", "Arena Cuts Loss, Misses Estimates - Analyst Blog", "Good News for Gilead's HIV Pipeline - Analyst Blog", "Pre-Market Earnings Report for March 7, 2013 : CNQ, KR, BTE, SFD, NAV, JW/A, FGP, CIEN, EPL, PRIM, CMN, CLDX", "JAZZ Beats EPS, Misses Sales - Analyst Blog", "Steve Cohen Increases Celldex Up 145%", "Pre-Market Most Active for Feb 6, 2013 : ELN, QQQ, BAC, BBRY, ZNGA, NOK, GSK, VMED, KB, SNY, ARMH, CLDX", "Pre-Market Most Active for Dec 11, 2012 : AIG, BAC, HTZ, NOK, FB, HCA, GSK, SIRI, AAPL, URBN, QQQ, CLDX", "Pre-Market Earnings Report for August 10, 2012 : BAM, JCP, HAR, CYD, HSFT, CLDX, HZNP, SCR, XIN, URRE, HSKA, DLGC", "Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VOD", "After Hours Most Active for May 23, 2012 : NTAP, HPQ, BAC, BLK, IFSIA, QQQ, F, CLDX, KMI, PFE, ERIC, FB", "To Partner or Not to Partner: That Is the Question", "Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer", "Celgene's Apremilast Encourages - Analyst Blog", "Monday Losers: Delcath, CVS Caremark and Coldwater Creek", "Curtain Closes on ASCO: 2010's Few Winners"], "Elapsed Time": ["6 DAYS AGO", "JUN 19, 2020", "JUN 16, 2020", "JUN 8, 2020", "NOV 13, 2019", "NOV 4, 2019", "AUG 8, 2019", "AUG 8, 2019", "6 DAYS AGO", "APR 8, 2019", "MAR 20, 2019", "MAR 8, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 7, 2019", "FEB 22, 2019", "AUG 7, 2019", "FEB 13, 2019", "DEC 21, 2018", "DEC 10, 2018", "DEC 7, 2018", "NOV 9, 2018", "NOV 8, 2018", "NOV 8, 2018", "FEB 14, 2019", "FEB 13, 2019", "DEC 21, 2018", "AUG 23, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 8, 2018", "NOV 7, 2018", "JUL 2, 2018", "JUN 29, 2018", "JUN 11, 2018", "MAY 11, 2018", "MAY 10, 2018", "MAY 10, 2018", "MAY 3, 2018", "JUL 30, 2018", "APR 23, 2018", "APR 22, 2018", "APR 18, 2018", "APR 17, 2018", "APR 16, 2018", "APR 16, 2018", "APR 16, 2018", "APR 25, 2018", "APR 16, 2018", "APR 16, 2018", "APR 16, 2018", "APR 16, 2018", "APR 10, 2018", "APR 3, 2018", "MAR 13, 2018", "APR 16, 2018", "MAR 12, 2018", "MAR 9, 2018", "MAR 8, 2018", "MAR 8, 2018", "MAR 8, 2018", "MAR 6, 2018", "MAR 5, 2018", "MAR 13, 2018", "MAR 1, 2018", "FEB 16, 2018", "JAN 31, 2018", "JAN 21, 2018", "JAN 16, 2018", "JAN 9, 2018", "JAN 9, 2018", "MAR 5, 2018", "JAN 3, 2018", "JAN 2, 2018", "DEC 29, 2017", "DEC 21, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 14, 2017", "JAN 8, 2018", "DEC 10, 2017", "DEC 1, 2017", "DEC 1, 2017", "NOV 30, 2017", "NOV 29, 2017", "NOV 20, 2017", "NOV 8, 2017", "DEC 13, 2017", "DEC 10, 2017", "DEC 1, 2017", "NOV 7, 2017", "NOV 1, 2017", "OCT 24, 2017", "OCT 18, 2017", "OCT 17, 2017", "NOV 8, 2017", "SEP 25, 2017", "SEP 21, 2017", "AUG 24, 2017", "AUG 24, 2017", "AUG 19, 2017", "AUG 14, 2017", "AUG 9, 2017", "OCT 6, 2017", "AUG 2, 2017", "JUL 19, 2017", "JUL 14, 2017", "JUN 24, 2017", "JUN 18, 2017", "JUN 13, 2017", "JUN 12, 2017", "AUG 9, 2017", "JUN 6, 2017", "JUN 5, 2017", "JUN 1, 2017", "MAY 26, 2017", "MAY 21, 2017", "MAY 18, 2017", "MAY 10, 2017", "JUN 11, 2017", "MAY 9, 2017", "MAY 2, 2017", "APR 24, 2017", "APR 23, 2017", "APR 21, 2017", "APR 21, 2017", "APR 20, 2017", "MAY 10, 2017", "APR 19, 2017", "APR 17, 2017", "APR 15, 2017", "APR 7, 2017", "APR 1, 2017", "MAR 25, 2017", "MAR 15, 2017", "APR 20, 2017", "MAR 14, 2017", "MAR 12, 2017", "MAR 10, 2017", "MAR 9, 2017", "MAR 7, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 14, 2017", "FEB 28, 2017", "FEB 24, 2017", "FEB 22, 2017", "FEB 8, 2017", "FEB 5, 2017", "JAN 29, 2017", "JAN 25, 2017", "MAR 3, 2017", "JAN 9, 2017", "JAN 5, 2017", "DEC 23, 2016", "DEC 21, 2016", "DEC 19, 2016", "DEC 15, 2016", "DEC 12, 2016", "JAN 19, 2017", "DEC 7, 2016", "DEC 6, 2016", "NOV 29, 2016", "NOV 28, 2016", "NOV 20, 2016", "NOV 15, 2016", "NOV 14, 2016", "DEC 7, 2016", "NOV 9, 2016", "NOV 8, 2016", "NOV 7, 2016", "NOV 1, 2016", "OCT 31, 2016", "OCT 25, 2016", "OCT 18, 2016", "NOV 9, 2016", "NOV 9, 2016", "NOV 8, 2016", "NOV 7, 2016", "OCT 4, 2016", "OCT 4, 2016", "OCT 3, 2016", "OCT 3, 2016", "OCT 17, 2016", "OCT 11, 2016", "OCT 4, 2016", "AUG 18, 2016", "AUG 12, 2016", "AUG 9, 2016", "AUG 9, 2016", "SEP 27, 2016", "AUG 3, 2016", "JUL 19, 2016", "JUL 13, 2016", "JUL 8, 2016", "JUN 29, 2016", "JUN 15, 2016", "JUN 6, 2016", "AUG 4, 2016", "MAY 24, 2016", "MAY 23, 2016", "MAY 9, 2016", "MAY 6, 2016", "MAY 3, 2016", "MAY 2, 2016", "JUN 1, 2016", "MAY 31, 2016", "MAY 24, 2016", "MAY 23, 2016", "MAY 9, 2016", "MAY 6, 2016", "MAY 3, 2016", "APR 6, 2016", "APR 29, 2016", "APR 4, 2016", "MAR 30, 2016", "MAR 21, 2016", "MAR 17, 2016", "MAR 15, 2016", "MAR 13, 2016", "MAR 10, 2016", "APR 4, 2016", "MAR 8, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 8, 2016", "MAR 7, 2016", "MAR 2, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 26, 2016", "FEB 25, 2016", "FEB 23, 2016", "MAR 7, 2016", "FEB 22, 2016", "FEB 9, 2016", "FEB 4, 2016", "FEB 2, 2016", "JAN 28, 2016", "JAN 17, 2016", "JAN 15, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 9, 2016", "FEB 4, 2016", "DEC 1, 2015", "NOV 24, 2015", "NOV 23, 2015", "JAN 13, 2016", "NOV 23, 2015", "NOV 20, 2015", "NOV 9, 2015", "NOV 9, 2015", "NOV 8, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 23, 2015", "NOV 23, 2015", "OCT 16, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 14, 2015", "OCT 5, 2015", "OCT 1, 2015", "NOV 2, 2015", "AUG 26, 2015", "AUG 25, 2015", "AUG 24, 2015", "AUG 11, 2015", "AUG 11, 2015", "AUG 11, 2015", "AUG 11, 2015", "SEP 15, 2015", "AUG 26, 2015", "JUN 30, 2015", "JUN 21, 2015", "JUN 5, 2015", "JUN 2, 2015", "MAY 30, 2015", "AUG 6, 2015", "MAY 24, 2015", "MAY 11, 2015", "MAY 6, 2015", "APR 29, 2015", "APR 29, 2015", "APR 22, 2015", "APR 20, 2015", "MAY 28, 2015", "APR 7, 2015", "APR 5, 2015", "MAR 31, 2015", "MAR 29, 2015", "MAR 18, 2015", "MAR 17, 2015", "MAR 5, 2015", "APR 10, 2015", "MAR 4, 2015", "MAR 2, 2015", "FEB 26, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 23, 2015", "FEB 23, 2015", "MAR 4, 2015", "FEB 23, 2015", "FEB 23, 2015", "JAN 30, 2015", "JAN 26, 2015", "JAN 19, 2015", "JAN 16, 2015", "DEC 16, 2014", "FEB 23, 2015", "FEB 23, 2015", "NOV 18, 2014", "NOV 17, 2014", "NOV 17, 2014", "NOV 6, 2014", "OCT 31, 2014", "OCT 23, 2014", "DEC 5, 2014", "NOV 18, 2014", "NOV 18, 2014", "JUN 6, 2014", "JUN 5, 2014", "MAY 30, 2014", "MAY 29, 2014", "SEP 26, 2014", "SEP 10, 2014", "MAY 27, 2014", "MAY 21, 2014", "MAY 15, 2014", "MAY 15, 2014", "MAY 14, 2014", "MAY 9, 2014", "MAY 29, 2014", "MAY 1, 2014", "MAY 1, 2014", "APR 8, 2014", "MAR 24, 2014", "MAR 24, 2014", "MAR 24, 2014", "MAR 4, 2014", "MAY 5, 2014", "MAR 3, 2014", "MAR 3, 2014", "FEB 28, 2014", "FEB 27, 2014", "FEB 20, 2014", "DEC 19, 2013", "DEC 5, 2013", "MAR 4, 2014", "MAR 3, 2014", "MAR 3, 2014", "NOV 7, 2013", "OCT 30, 2013", "SEP 18, 2013", "AUG 26, 2013", "NOV 25, 2013", "AUG 12, 2013", "AUG 12, 2013", "AUG 1, 2013", "JUL 5, 2013", "JUL 2, 2013", "JUN 17, 2013", "APR 23, 2013", "AUG 21, 2013", "MAR 12, 2013", "MAR 11, 2013", "MAR 11, 2013", "MAR 8, 2013", "MAR 7, 2013", "MAR 6, 2013", "MAR 5, 2013", "APR 6, 2013", "FEB 6, 2013", "DEC 11, 2012", "AUG 9, 2012", "MAY 24, 2012", "MAY 23, 2012", "MAR 10, 2011", "OCT 26, 2010", "MAR 4, 2013", "JUN 7, 2010", "JUN 9, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/3-healthcare-stocks-that-surged-last-week-2020-06-21", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-stock-is-soaring-today-2020-06-19", "https://www.nasdaq.com/articles/fda-nod-for-jazzs-drug-bysis-protective-2-trial-meets-goals-edsa-to-begin-covid-19-drug", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-08-2020%3A-opnt-teva-cldx-srpt-xlv-ibb-2020-06-08", "https://www.nasdaq.com/articles/financial-sector-update-for-11-13-2019%3A-bpyjpmcldxknslnni-2019-11-13", "https://www.nasdaq.com/articles/todays-top-6-gainers-in-healthcare-sector-agrx-bntx-sibn...-2019-11-04", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-cldx-q2-2019-earnings-call-transcript-2019-08-08", "https://www.nasdaq.com/articles/celldex-therapeutics-keeps-up-its-penny-pinching-and-pipeline-progress-2019-08-08", "https://www.nasdaq.com/articles/3-healthcare-stocks-that-surged-last-week-2020-06-21", "https://www.nasdaq.com/articles/7-top-gainers-healthcare-sector-phas-mlnt-ttoo...-2019-04-08", "https://www.nasdaq.com/articles/is-celldex-therapeutics-cldx-stock-outpacing-its-medical-peers-this-year-2019-03-20", "https://www.nasdaq.com/articles/celldex-cldx-q4-loss-narrower-than-expected-sales-beat-2019-03-08", "https://www.nasdaq.com/articles/celldex-therapeutics-cost-cutting-and-reverse-stock-split-help-keep-it-rolling-2019-03-08", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-cldx-q4-2018-earnings-conference-call-transcript-2019-03-07", "https://www.nasdaq.com/articles/earnings-reaction-history-celldex-therapt-1000-follow-through-indicator-44-sensitive-2019", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-stock-sinks-as-market-gains%3A-what-you-should-know-2019-02-22", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-celldex-therapeutics-inc.-q2-earnings-report-2019-08-07", "https://www.nasdaq.com/articles/5-tiny-biotech-stocks-superb-growth-potential-2019-02-13", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-sank-friday-2018-12-21", "https://www.nasdaq.com/articles/why-celldex-therapeutics-jumping-today-2018-12-10", "https://www.nasdaq.com/articles/why-is-celldex-cldx-down-29-since-last-earnings-report-2018-12-07", "https://www.nasdaq.com/articles/celldex-cldx-q3-earnings-beat-estimates-revenues-miss-2018-11-09", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-chugs-along-3rd-quarter-despite-challenges-2018-11-08", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-inc-surged-thursday-2018-11-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biodelivery-cytokinetics-celldex-aduro-and-aeterna-2019", "https://www.nasdaq.com/articles/5-tiny-biotech-stocks-superb-growth-potential-2019-02-13", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-sank-friday-2018-12-21", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-shares-jumped-wednesday-2018-08-23", "https://www.nasdaq.com/articles/celldex-cldx-q2-earnings-and-revenues-surpass-estimates-2018-08-09", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-spending-cuts-help-preserve-cash-2nd-quarter-2018-08-09", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-reports-q2-loss-tops-revenue-estimates-2018-08-08", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-reports-q3-loss-lags-revenue-estimates-2018-11-07", "https://www.nasdaq.com/articles/how-david-gardners-biggest-losers-demonstrate-why-long-term-investing-wins-2018-07-02", "https://www.nasdaq.com/articles/better-buy-ziopharm-oncology-inc-vs-celldex-therapeutics-2018-06-29", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-down-9.2-since-earnings-report%3A-can-it-rebound-2018-06-11", "https://www.nasdaq.com/articles/celldex-cldx-q1-loss-wider-than-expected-shares-down-2018-05-11", "https://www.nasdaq.com/articles/celldex-cldx-q1-loss-narrower-revenues-beat-shares-down-2018-05-10", "https://www.nasdaq.com/articles/celldex-therapeutics-moves-forward-after-glemba-clinical-failure-2018-05-10", "https://www.nasdaq.com/articles/whats-in-store-for-celldex-cldx-this-earnings-season-2018-05-03", "https://www.nasdaq.com/articles/whats-in-store-for-celldex-cldx-this-earnings-season-2018-07-30", "https://www.nasdaq.com/articles/it-game-over-celldex-2018-04-23", "https://www.nasdaq.com/articles/johnson-johnsons-first-quarter-2018-earnings-review-2018-04-22", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alks-up-cldx-down-alxn-to-acquire-wilson-therapeutics-2018-04-18", "https://www.nasdaq.com/articles/celldexs-phase-ii-breast-cancer-study-fails-shares-plunge-2018-04-17", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-over-1-eldorado-resorts-shares-surge-2018-04-16", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-bank-america-earnings-top-estimates-2018-04", "https://www.nasdaq.com/articles/health-care-sector-update-04162018-alks-cldx-apri-2018-04-16", "https://www.nasdaq.com/articles/lessons-learn-aprils-biotech-blowups-2018-04-25", "https://www.nasdaq.com/articles/health-care-sector-update-04162018-shpscldxalksapri-2018-04-16", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-rises-300-points-apricus-biosciences-shares-plummet-2018", "https://www.nasdaq.com/articles/health-care-sector-update-04162018-cldxalksapri-2018-04-16", "https://www.nasdaq.com/articles/monday-sector-laggards-drugs-agriculture-farm-products-2018-04-16", "https://www.nasdaq.com/articles/implied-volatility-surging-for-celldex-therapeutics-cldx-stock-options-2018-04-10", "https://www.nasdaq.com/articles/3-top-small-cap-biotech-stocks-aggressive-investors-2018-04-03", "https://www.nasdaq.com/articles/why-celldex-therapeutics-stock-crashed-february-2018-03-13", "https://www.nasdaq.com/articles/why-celldex-therapeutics-stock-cratering-today-2018-04-16", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-march-2018-03-12", "https://www.nasdaq.com/articles/celldex-therapeutics-make-or-break-it-data-expected-soon-2018-03-09", "https://www.nasdaq.com/articles/celldex-cldx-q4-loss-narrows-revenues-beat-shares-up-2018-03-08", "https://www.nasdaq.com/articles/celldex-therapeutics-finishes-2017-plenty-cash-and-high-hopes-2018-03-08", "https://www.nasdaq.com/articles/why-celldex-therapeutics-shot-today-2018-03-08", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q4-earnings%3A-whats-in-store-2018-03-06", "https://www.nasdaq.com/articles/whats-in-the-cards-for-merck-kgaa-mkgaf-in-q4-earnings-2018-03-05", "https://www.nasdaq.com/articles/celldex-therapeutics-stock-about-skyrocket-2018-03-13", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-celldex-cldx-in-q4-earnings-2018-03-01", "https://www.nasdaq.com/articles/3-stocks-could-put-teslas-returns-shame-2018-02-16", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-cldx-buy-2018-01-31", "https://www.nasdaq.com/articles/3-growth-stocks-could-put-shopifys-returns-shame-2018-01-21", "https://www.nasdaq.com/articles/will-2018-be-celldex-therapeutics-incs-best-year-yet-2018-01-16", "https://www.nasdaq.com/articles/amgen-announces-acceptance-of-maa-for-evenity-in-europe-2018-01-09", "https://www.nasdaq.com/articles/abbvies-upadacitinib-gains-breakthrough-therapy-designation-2018-01-09", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2018-03-05", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-january-2018-01-03", "https://www.nasdaq.com/articles/4-reasons-to-include-celldex-cldx-stock-in-your-portfolio-2018-01-02", "https://www.nasdaq.com/articles/therapeuticsmd-submits-nda-for-vms-candidate-shares-rise-2017-12-29", "https://www.nasdaq.com/articles/abbvies-ra-candidate-meets-endpoints-in-3rd-phase-iii-study-2017-12-21", "https://www.nasdaq.com/articles/minerva-initiates-phase-iii-study-on-schizophrenia-candidate-2017-12-20", "https://www.nasdaq.com/articles/therapeuticsmd-falls-despite-acceptance-of-nda%3A-heres-why-2017-12-20", "https://www.nasdaq.com/articles/shires-new-formulation-of-oncaspar-gets-approval-in-europe-2017-12-14", "https://www.nasdaq.com/articles/ultragenyx-announces-interim-data-from-early-stage-study-2018-01-08", "https://www.nasdaq.com/articles/why-celldex-therapeutics-stock-reversed-course-november-2017-12-10", "https://www.nasdaq.com/articles/cancer-space-update%3A-pfizers-bavencio-fails-in-phase-iii-2017-12-01", "https://www.nasdaq.com/articles/celldex-begins-phase-i-trial-on-cancer-candidate-cdx-1140-2017-12-01", "https://www.nasdaq.com/articles/better-buy-ziopharm-oncology-inc-vs-celldex-therapeutics-inc-2017-11-30", "https://www.nasdaq.com/articles/heres-where-things-went-wrong-celldex-therapeutics-inc-2017-2017-11-29", "https://www.nasdaq.com/articles/celldex-cldx-initiates-phase-ii-study-on-cancer-candidate-2017-11-20", "https://www.nasdaq.com/articles/celldex-cldx-q3-loss-narrows-revenues-beat-shares-up-2017-11-08", "https://www.nasdaq.com/articles/glaxos-nucala-label-expansion-application-gets-fda-approval-2017-12-13", "https://www.nasdaq.com/articles/why-celldex-therapeutics-stock-reversed-course-november-2017-12-10", "https://www.nasdaq.com/articles/cancer-space-update%3A-pfizers-bavencio-fails-in-phase-iii-2017-12-01", "https://www.nasdaq.com/articles/why-celldex-therapeutics-jumped-higher-today-2017-11-07", "https://www.nasdaq.com/articles/celldex-cldx-to-report-q3-earnings%3A-whats-in-the-cards-2017-11-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-over-1-polaris-shares-surge-upbeat-earnings-2017-10", "https://www.nasdaq.com/articles/10-stunning-numbers-you-need-know-about-breast-cancer-2017-10-18", "https://www.nasdaq.com/articles/better-buy-ziopharm-oncology-inc-vs-celldex-therapeutics-2017-10-17", "https://www.nasdaq.com/articles/how-invest-biotech-stocks-2017-11-08", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-jumped-higher-today-2017-09-25", "https://www.nasdaq.com/articles/3-small-cap-biotech-stocks-buy-fall-2017-09-21", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-now-2017-08-24", "https://www.nasdaq.com/articles/celldex-ends-phase-ii-enrollment-for-breast-cancer-candidate-2017-08-24", "https://www.nasdaq.com/articles/3-top-biotech-stocks-under-10-2017-08-19", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-are-they-bargains-2017-08-14", "https://www.nasdaq.com/articles/celldex-cldx-q2-loss-narrows-revenues-beat-shares-up-2017-08-09", "https://www.nasdaq.com/articles/whats-behind-celldex-therapeutics-incs-16-rally-september-2017-10-06", "https://www.nasdaq.com/articles/whats-in-the-cards-for-celldex-cldx-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-juno-therapeutics-2017-07-19", "https://www.nasdaq.com/articles/down-148-celldex-therapeutics-stock-incredible-bargain-2017-07-14", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2017-06-24", "https://www.nasdaq.com/articles/3-stocks-universal-display-return-potential-2017-06-18", "https://www.nasdaq.com/articles/why-is-celldex-cldx-down-27-since-the-last-earnings-report-2017-06-13", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-are-they-bargains-2017-06-12", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-finishes-second-quarter-plenty-cash-and-clinical-momentum-2017-08", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-inc-fell-today-2017-06-06", "https://www.nasdaq.com/articles/heres-what-shaved-14-celldex-therapeutics-incs-stock-price-may-2017-06-05", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-bear-case-bull-2017-06-01", "https://www.nasdaq.com/articles/celldexs-immuno-oncology-pipeline-continues-to-impress-2017-05-26", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-agenus-inc-2017-05-21", "https://www.nasdaq.com/articles/3-value-stocks-bold-investors-2017-05-18", "https://www.nasdaq.com/articles/celldex-cldx-q1-loss-in-line-revenues-beat-shares-up-2017-05-10", "https://www.nasdaq.com/articles/3-stocks-look-just-oracle-1986-2017-06-11", "https://www.nasdaq.com/articles/celldex-therapeutics-incs-collaboration-bristol-myers-squibb-key-first-quarter-update-2017", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-q1-earnings%3A-whats-in-store-2017-05-02", "https://www.nasdaq.com/articles/meditor-group-ltd-buys-celldex-therapeutics-sells-vivus-2017-04-24", "https://www.nasdaq.com/articles/read-you-buy-biotech-stocks-2017-04-23", "https://www.nasdaq.com/articles/whats-in-store-for-glaxosmithkline-gsk-in-q1-earnings-2017-04-21", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q1-earnings%3A-will-it-beat-again-2017-04-21", "https://www.nasdaq.com/articles/eli-lilly-lly-to-report-q1-earnings%3A-whats-in-the-cards-2017-04-20", "https://www.nasdaq.com/articles/3-stocks-could-double-your-investment-2017-05-10", "https://www.nasdaq.com/articles/why-is-celldex-cldx-down-4.4-since-the-last-earnings-report-2017-04-19", "https://www.nasdaq.com/articles/3-cancer-drug-stocks-could-make-you-rich-2017-04-17", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-sale-2017-04-15", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2017-04-07", "https://www.nasdaq.com/articles/3-top-stocks-youve-been-overlooking-2017-04-01", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2017-03-25", "https://www.nasdaq.com/articles/celldex-cldx-shares-up-as-q4-loss-narrows-sales-beat-2017-03-15", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2017-04-20", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-14-2017-htht-akao-cldx-fogo-nptn-arna-ccxi-kura-drrx", "https://www.nasdaq.com/articles/3-horrible-stocks-retirees-2017-03-12", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-celldex-therapeutics-2017-03-10", "https://www.nasdaq.com/articles/spectrum-sppi-q4-loss-narrower-than-expected-sales-beat-2017-03-09", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-feeling-some-pressure-today-heres-why-2017-03-07", "https://www.nasdaq.com/articles/why-celldex-therapeutics-stock-gained-10-february-2017-03-06", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-q4-earnings%3A-whats-in-store-2017-03-06", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-ends-q4-plenty-cash-and-several-key-studies-progressing-2017-03", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-juno-therapeutics-inc-2017-02-28", "https://www.nasdaq.com/articles/3-biotech-long-shots-boom-or-bust-2017-02-24", "https://www.nasdaq.com/articles/looking-back-david-gardners-worst-stock-picks-past-3-years-2017-02-22", "https://www.nasdaq.com/articles/why-celldex-therapeutics-stock-fell-almost-10-january-2017-02-08", "https://www.nasdaq.com/articles/3-stocks-could-make-you-rich-2017-02-05", "https://www.nasdaq.com/articles/3-biotech-stocks-id-buy-right-now-2017-01-29", "https://www.nasdaq.com/articles/5-small-cap-biotech-stocks-buy-february-2017-01-25", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2017-03-03", "https://www.nasdaq.com/articles/why-celldex-therapeutics-imploded-2016-2017-01-09", "https://www.nasdaq.com/articles/celldex-therapeutics-incs-3-best-moves-2016-2017-01-05", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-exelixis-2016-12-23", "https://www.nasdaq.com/articles/2016s-worst-clinical-failures-2016-12-21", "https://www.nasdaq.com/articles/how-value-clinical-stage-biotech-stocks-2016-12-19", "https://www.nasdaq.com/articles/celldex-therapeutics-incs-biggest-failure-2016-2016-12-15", "https://www.nasdaq.com/articles/3-cheap-healthcare-stocks-you-can-buy-right-now-2016-12-12", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-you-can-buy-right-now-2017-01-19", "https://www.nasdaq.com/articles/why-celldex-rallied-22-november-2016-12-07", "https://www.nasdaq.com/articles/why-you-should-and-shouldnt-buy-celldex-therapeutics-inc-2016-12-06", "https://www.nasdaq.com/articles/down-117-celldex-therapeutics-now-buy-2016-11-29", "https://www.nasdaq.com/articles/mid-afternoon-market-update-fang-holdings-drops-following-q3-results-recro-pharma-shares", "https://www.nasdaq.com/articles/ready-get-biotech-check-out-these-3-stocks-2016-11-20", "https://www.nasdaq.com/articles/celldex-stock-up-on-positive-data-on-new-cancer-candidate-2016-11-15", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-stock-jumped-higher-again-today-2016-11-14", "https://www.nasdaq.com/articles/is-celldex-therapeutics-cldx-stock-a-solid-choice-right-now-2016-12-07", "https://www.nasdaq.com/articles/celldex-cldx-q3-loss-narrower-than-expected-sales-beat-2016-11-09", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-jumped-higher-today-2016-11-08", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-watches-its-cash-q3-ready-expand-2016-11-07", "https://www.nasdaq.com/articles/3-biotech-stocks-could-double-12-months-2016-11-01", "https://www.nasdaq.com/articles/celldex-cldx%3A-will-the-stock-surprise-in-q3-earnings-2016-10-31", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-bluebird-bio-inc-2016-10-25", "https://www.nasdaq.com/articles/better-buy-nantkwest-inc-vs-celldex-therapeutics-inc-2016-10-18", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-stock-tumbled-22-october-2016-11-09", "https://www.nasdaq.com/articles/celldex-cldx-q3-loss-narrower-than-expected-sales-beat-2016-11-09", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-jumped-higher-today-2016-11-08", "https://www.nasdaq.com/articles/why-endurance-specialty-holdings-celldex-therapeutics-and-sears-holdings-jumped-today-2016", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-drops-more-100-points-summit-therapeutics-shares-spike", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-jumped-higher-today-2016-10-04", "https://www.nasdaq.com/articles/forget-celldex-therapeutics-inc-these-2-stocks-doubled-last-year-2016-10-03", "https://www.nasdaq.com/articles/10-biotech-stocks-to-put-on-your-radar-this-quarter-2016-10-03", "https://www.nasdaq.com/articles/risky-biotech-stock-about-jump-higher-2016-10-17", "https://www.nasdaq.com/articles/these-3-little-biotechs-just-scored-big-2016-10-11", "https://www.nasdaq.com/articles/3-beaten-healthcare-stocks-are-they-bargains-2016-10-04", "https://www.nasdaq.com/articles/we-did-math-xbi-can-go-83-2016-08-18", "https://www.nasdaq.com/articles/how-risky-celldex-therapeutics-inc-2016-08-12", "https://www.nasdaq.com/articles/celldex-therapeutics-incs-q2-results-hint-another-stock-offering-2016-08-09", "https://www.nasdaq.com/articles/celldex-cldx-posts-narrower-q2-loss-focus-pipeline-2016-08-09", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-ran-higher-today-2016-09-27", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-celldex-therapeutics-2016-08-03", "https://www.nasdaq.com/articles/3-biotech-stocks-could-soar-over-next-12-months-2016-07-19", "https://www.nasdaq.com/articles/5-things-celldex-therapeutics-inc-wants-you-know-2016-07-13", "https://www.nasdaq.com/articles/3-shocking-biotech-flops-2016-so-far-2016-07-08", "https://www.nasdaq.com/articles/these-3-biotechs-are-down-more-36-year-and-theyre-bargains-2016-06-29", "https://www.nasdaq.com/articles/4-cancer-drug-developers-you-need-have-your-radar-year-2016-06-15", "https://www.nasdaq.com/articles/celldex-cldx-presents-phase-ii-melanoma-study-data-2016-06-06", "https://www.nasdaq.com/articles/celldex-cldx-whats-ahead-stock-q2-earnings-2016-08-04", "https://www.nasdaq.com/articles/the-10-best-healthcare-stocks-to-buy-now-2016-05-24", "https://www.nasdaq.com/articles/3-reasons-celldex-therapeutics-stock-could-rise-2016-05-23", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-over-25-horizon-pharma-shares-rise-following", "https://www.nasdaq.com/articles/celldex-cldx-posts-wider-q1-loss-focus-pipeline-2016-05-06", "https://www.nasdaq.com/articles/biotech-stocks-earnings-preview%3A-regn-lgnd-ecyt-more-2016-05-03", "https://www.nasdaq.com/articles/celldex-cldx%3A-whats-ahead-for-the-stock-in-q1-earnings-2016-05-02", "https://www.nasdaq.com/articles/5-billionaires-just-bought-33-million-shares-celldex-therapeutics-2016-06-01", "https://www.nasdaq.com/articles/better-buy-celldex-therapeutics-inc-vs-ionis-pharmaceuticals-inc-2016-05-31", "https://www.nasdaq.com/articles/the-10-best-healthcare-stocks-to-buy-now-2016-05-24", "https://www.nasdaq.com/articles/3-reasons-celldex-therapeutics-stock-could-rise-2016-05-23", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-over-25-horizon-pharma-shares-rise-following", "https://www.nasdaq.com/articles/celldex-cldx-posts-wider-q1-loss-focus-pipeline-2016-05-06", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-ibb-2016-04-07", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-stock-sank-50-march-2016-04-06", "https://www.nasdaq.com/articles/one-drug-alone-makes-celldex-therapeutics-inc-buy-hint-its-not-rintega-2016-04-29", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-ilf-2016-04-04", "https://www.nasdaq.com/articles/why-galena-biopharma-inc-presented-higher-stock-price-2016-03-30", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-bounces-higher-2016-03-21", "https://www.nasdaq.com/articles/what-celldex-therapeutics-incs-failure-teaches-biotech-investors-about-risk-2016-03-17", "https://www.nasdaq.com/articles/what-rintegas-clinical-trial-flop-means-celldex-therapeutics-future-2016-03-15", "https://www.nasdaq.com/articles/3-big-risks-biotech-stocks-face-2016-03-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-abbvie-vertex-celldex-and-celgene-2016-03-10", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-sure-loves-mondays-2016-04-04", "https://www.nasdaq.com/articles/celldex-advised-to-discontinue-phase-iii-study-on-rintega-2016-03-08", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-higher-comscore-shares-drop-2016-03-07", "https://www.nasdaq.com/articles/downgrades-3-things-you-must-know-about-crash-celldex-therapeutics-2016-03-07", "https://www.nasdaq.com/articles/why-celldex-therapeutics-cldx-down-big-today-2016-03-07", "https://www.nasdaq.com/articles/celldex-therapeutics-stock-getting-crushed-today-heres-why-2016-03-07", "https://www.nasdaq.com/articles/us-markets-set-open-lower-despite-oil-gains-2016-03-07", "https://www.nasdaq.com/articles/us-futures-take-breather-after-last-weeks-rally-oil-gains-2016-03-07", "https://www.nasdaq.com/articles/health-care-sector-update-03082016-cldx-xbit-2016-03-08", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-5-pier-1-imports-shares-spike-higher-2016-03-07", "https://www.nasdaq.com/articles/waiting-celldex-therapeutics-inc-2016-03-02", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-and-bluebird-bio-inc-jumped-today-2016-03-01", "https://www.nasdaq.com/articles/why-celldex-therapeutics-and-momenta-pharmaceuticals-traded-down-today-2016-02-29", "https://www.nasdaq.com/articles/celldexs-q4-loss-narrower-than-expected-focus-on-pipeline-2016-02-26", "https://www.nasdaq.com/articles/celldexs-cldx-q4-loss-a-penny-narrower-than-expected-2016-02-25", "https://www.nasdaq.com/articles/6-stocks-to-buy-now-for-battered-bargains-2016-02-23", "https://www.nasdaq.com/articles/mondays-etf-unusual-volume-itot-2016-03-07", "https://www.nasdaq.com/articles/health-care-sector-update-02222016-cldx-vcel-2016-02-22", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-got-crushed-january-2016-02-09", "https://www.nasdaq.com/articles/why-did-biotech-fall-cliff-january-2016-02-04", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-slips-some-more-2016-02-02", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-gets-rocked-data-approaches-2016-01-28", "https://www.nasdaq.com/articles/3-biotech-stocks-jaw-dropping-growth-potential-2016-2016-01-17", "https://www.nasdaq.com/articles/after-hours-most-active-jan-15-2016-exr-mscc-dyax-bac-nktr-atw-epr-nbix-cldx-nvax-bx-hpe", "https://www.nasdaq.com/articles/whats-in-store-for-celldex-cldx-this-earnings-season-2016-02-22", "https://www.nasdaq.com/articles/health-care-sector-update-02222016-cldx-vcel-2016-02-22", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-got-crushed-january-2016-02-09", "https://www.nasdaq.com/articles/why-did-biotech-fall-cliff-january-2016-02-04", "https://www.nasdaq.com/articles/will-celldex-cldx-continue-to-surge-higher-2015-12-01", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-in-focus%3A-stock-rises-11.9-2015-11-24", "https://www.nasdaq.com/articles/celldex-jumps-on-phase-ii-overall-survival-data-on-rintega-2015-11-23", "https://www.nasdaq.com/articles/why-shares-celldex-therapeutics-dropped-10-today-2016-01-13", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-ilf-2015-11-23", "https://www.nasdaq.com/articles/why-celldex-therapeutics-shares-jumped-today-2015-11-20", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-second-straight-day-2015-11-09", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-rwx-2015-11-09", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-earnings-waiting-act-2015-11-08", "https://www.nasdaq.com/articles/celldexs-q3-loss-narrower-than-expected-focus-on-pipeline-2015-11-06", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-bounded-higher-today-2015-11-06", "https://www.nasdaq.com/articles/celldex-therapeutics-shares-are-surging-higher-2015-11-23", "https://www.nasdaq.com/articles/3-cancer-companies-watch-closely-2016-2015-10-20", "https://www.nasdaq.com/articles/after-hours-most-active-oct-16-2015-pdli-dyax-nvax-cldx-qqq-juno-ge-eca-pbr-pfe-cppl-bac", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-juno-therapeutics-kite-pharma-merck-bristol-myers", "https://www.nasdaq.com/articles/breaking-down-biotechs-bloodbath-which-companies-buy-2015-10-15", "https://www.nasdaq.com/articles/5-stocks-searching-cancer-cure-right-now-2015-10-14", "https://www.nasdaq.com/articles/why-celldex-shares-jumped-12-friday-2015-10-05", "https://www.nasdaq.com/articles/5-top-stocks-buy-october-2015-10-01", "https://www.nasdaq.com/articles/can-celldex-cldx-surprise-estimates-in-q3-earnings-2015-11-02", "https://www.nasdaq.com/articles/celldex-cldx-shows-strength%3A-stock-adds-8.2-in-session-2015-08-26", "https://www.nasdaq.com/articles/why-shares-celldex-therapeutics-inc-soared-tuesday-2015-08-25", "https://www.nasdaq.com/articles/3-top-small-cap-biotech-stocks-buy-right-now-2015-08-24", "https://www.nasdaq.com/articles/heres-why-celldex-therapeutics-stock-got-crushed-today-2015-08-11", "https://www.nasdaq.com/articles/celldex-q2-loss-narrower-than-expected-pipeline-in-focus-analyst-blog-2015-08-11", "https://www.nasdaq.com/articles/3-key-things-know-about-celldex-therapeutics-incs-q2-results-2015-08-11", "https://www.nasdaq.com/articles/health-care-sector-update-08112015-cldx-kerx-rptp-2015-08-11", "https://www.nasdaq.com/articles/celldex-bargain-after-losing-third-its-value-last-month-2015-09-15", "https://www.nasdaq.com/articles/celldex-cldx-shows-strength%3A-stock-adds-8.2-in-session-2015-08-26", "https://www.nasdaq.com/articles/celldexs-rintega-phase-iii-study-recommended-to-continue-analyst-blog-2015-06-30", "https://www.nasdaq.com/articles/these-3-biotech-stocks-are-losing-money-wed-still-buy-them-2015-06-21", "https://www.nasdaq.com/articles/terrifying-cancer-may-finally-be-treatable-2015-06-05", "https://www.nasdaq.com/articles/celldex-glioblastoma-vaccine-hits-phase-ii-primary-endpoint-analyst-blog-2015-06-02", "https://www.nasdaq.com/articles/3-best-breed-biotech-stocks-2015-05-30", "https://www.nasdaq.com/articles/rsi-alert-celldex-therapeutics-cldx-now-oversold-2015-08-06", "https://www.nasdaq.com/articles/3-stock-market-tips-biotech-industry-2015-05-24", "https://www.nasdaq.com/articles/use-options-chance-buy-cldx-47-discount-2015-05-11", "https://www.nasdaq.com/articles/3-tiny-healthcare-stocks-you-ought-be-watching-2015-05-06", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-good-start-2015-2015-04-29", "https://www.nasdaq.com/articles/celldex-1q-loss-narrower-expected-pipeline-focus-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-fbt-icpt-pcyc-cldx-2015-04-22", "https://www.nasdaq.com/articles/health-care-sector-update-04202015-cldx-lgnd-lly-2015-04-20", "https://www.nasdaq.com/articles/first-week-cldx-july-17th-options-trading-2015-05-28", "https://www.nasdaq.com/articles/celldex-initiates-study-on-varlilumab-for-metastatic-melanoma-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/disruptive-innovation-changing-fight-against-cancer-2015-04-05", "https://www.nasdaq.com/articles/use-options-chance-buy-cldx-44-discount-2015-03-31", "https://www.nasdaq.com/articles/3-and-coming-biotech-stocks-watch-2015-03-29", "https://www.nasdaq.com/articles/celldex-roche-ink-deal-to-develop-kidney-cancer-drug-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/health-care-sector-update-03172015-cldx-bmrn-icpt-2015-03-17", "https://www.nasdaq.com/articles/bristol-myers-drug-shows-impressive-data-inks-deal-analyst-blog-2015-03-05", "https://www.nasdaq.com/articles/exelixis-cometriq-gets-fast-track-status-in-u.s.-analyst-blog-2015-04-10", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xbi-ilf-2015-03-04", "https://www.nasdaq.com/articles/use-options-chance-buy-cldx-53-discount-2015-03-02", "https://www.nasdaq.com/articles/pre-market-most-active-feb-26-2015-elx-bac-rig-aapl-crm-amt-pva-cybx-cldx-tvix-gogo-fb", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-q4-earnings-overshadowed-fda-news-2015-02-24", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-wider-than-expected-loss-in-q4-tale-of-the-tape-2015-02-24", "https://www.nasdaq.com/articles/health-care-sector-update-02232015-rigl-cldx-geva-2015-02-23", "https://www.nasdaq.com/articles/will-celldex-therapeutics-cldx-disappoint-this-earnings-analyst-blog-2015-02-23", "https://www.nasdaq.com/articles/why-celldex-therapeutics-inc-soaring-2015-03-04", "https://www.nasdaq.com/articles/why-shares-celldex-therapeutics-inc-skyrocketed-today-2015-02-23", "https://www.nasdaq.com/articles/monday-sector-leaders-drugs-biotechnology-stocks-2015-02-23", "https://www.nasdaq.com/articles/celldex-bristol-myers-initiate-phase-i-ii-solid-tumor-study-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/commit-purchase-celldex-therapeutics-18-earn-169-annualized-using-options-2015-01-26", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-jumps%3A-stock-moves-up-8.9-tale-of-the-tape-2015-01-19", "https://www.nasdaq.com/articles/after-hours-most-active-jan-16-2015-nvax-cldx-fxcm-t-pbr-pdli-amat-vtr-wfc-spls-bac-cmcsa", "https://www.nasdaq.com/articles/3-beaten-down-stocks-ready-bounce-back-2014-12-16", "https://www.nasdaq.com/articles/health-care-sector-update-02232015-cldxriglsppi-2015-02-23", "https://www.nasdaq.com/articles/why-shares-celldex-therapeutics-inc-skyrocketed-today-2015-02-23", "https://www.nasdaq.com/articles/celldex-therapeutics-surges-on-positive-rindopepimut-data-analyst-blog-2014-11-18", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-halliburton-acquire-baker-hughes-346-billion", "https://www.nasdaq.com/articles/health-care-sector-update-11172014-actagndrtxvrxvrxto-2014-11-17", "https://www.nasdaq.com/articles/celldex-falls-with-pipeline-update-overshadowing-q3-results-analyst-blog-2014-11-06", "https://www.nasdaq.com/articles/cldx-crosses-above-key-moving-average-level-2014-10-31", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-buy-now-2014-10-23", "https://www.nasdaq.com/articles/celldexs-glembatumumab-vedotin-in-phase-ii-for-melanoma-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/celldex-therapeutics-inc-cldx-focus-stock-soars-289-tale-tape-2014-11-18", "https://www.nasdaq.com/articles/celldex-therapeutics-surges-on-positive-rindopepimut-data-analyst-blog-2014-11-18", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-soars%3A-stock-adds-12.6-in-session-tale-of-the-tape-2014-06-06", "https://www.nasdaq.com/articles/thursdays-etf-movers-xbi-ewd-2014-06-05", "https://www.nasdaq.com/articles/oncothyreon-collaborates-with-celldex-analyst-blog-2014-05-30", "https://www.nasdaq.com/articles/healthcare-stocks-climbing-late-trade-celldex-oncothyreon-partnering-prospective-cancer", "https://www.nasdaq.com/articles/celldex-cldx-up-on-pilot-study-initiation-on-cdx-301-analyst-blog-2014-09-26", "https://www.nasdaq.com/articles/bristol-myers-cytomx-therapeutics-join-forces-analyst-blog-2014-05-28", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-gdxj-2014-05-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-celldex-incyte-tie-big-pharma-immuno-oncology-analyst-blog-2014-05", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-soars%3A-stock-adds-26.9-in-session-tale-of-the-tape-2014-05-15", "https://www.nasdaq.com/articles/celldex-gains-on-bristol-myers-squibb-deal-analyst-blog-2014-05-15", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-head-downward-commodities-continue-show-strength-2014", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-gdxj-2014-05-09", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-29", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-pre-market-mylan-q1-earnings-top-street-view-2014-05", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-01-1", "https://www.nasdaq.com/articles/encouraging-pre-clinical-data-from-celldex-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/mid-day-market-update-nasdaq-tumbles-165-nu-skin-shares-surge-after-aic-china-review", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-lower-renesola-swings-q4-profit-2014-03-24", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-recover-slightly-healthcare-stocks-continue-show", "https://www.nasdaq.com/articles/celldex-posts-narrower-than-expected-loss-in-q4-analyst-blog-2014-03-04", "https://www.nasdaq.com/articles/celldexs-q1-loss-widens-analyst-blog-2014-05-05", "https://www.nasdaq.com/articles/broad-based-declines-healthcare-stocks-celldex-down-11-after-q4-net-loss-widens-revenue", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-03", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-3-2014-mga-ssys-roc-nus-pgh-akrx-cldx-rba-evep-mgln-swc", "https://www.nasdaq.com/articles/interesting-cldx-put-and-call-options-april-19th-2014-02-27", "https://www.nasdaq.com/articles/agenus-acquisition-4-antibody-transformational-move-2014-02-20", "https://www.nasdaq.com/articles/celldex-some-thoughts-rindopepimut-2013-12-19", "https://www.nasdaq.com/articles/pre-market-most-active-dec-5-2013-nok-gtat-aapl-fb-bac-sol-aeg-cldx-drys-qqq-alu-ccl-2013", "https://www.nasdaq.com/articles/celldex-therapeutics-cldx-in-focus%3A-stock-tumbles-10.1-tale-of-the-tape-2014-03-04", "https://www.nasdaq.com/articles/broad-based-declines-healthcare-stocks-celldex-down-11-after-q4-net-loss-widens-revenue", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-03", "https://www.nasdaq.com/articles/mid-afternoon-market-update-twitter-ipo-wild-success-markets-slide-2013-11-07", "https://www.nasdaq.com/articles/celldex-whats-all-excitement-about-2013-10-30", "https://www.nasdaq.com/articles/agenus-thoughts-phase-ii-results-prophage-glioblastoma-2013-09-18", "https://www.nasdaq.com/articles/these-etfs-house-next-biotech-takeover-targets-2013-08-26", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-wal-mart-names-new-ceo-2013-11-25", "https://www.nasdaq.com/articles/mid-day-market-update-sysco-drops-q4-results-mcewen-mining-shares-rise-2013-08-12", "https://www.nasdaq.com/articles/mid-morning-market-update-us-markets-mixed-blackberry-explore-strategic-alternatives-2013", "https://www.nasdaq.com/articles/biotech-stocks-breast-cancer-drugs-clinical-trials-offer-new-hope-2013-08-01", "https://www.nasdaq.com/articles/market-wrap-july-5-stocks-oil-us-dollar-jump-wake-strong-payrolls-report-treasuries-and", "https://www.nasdaq.com/articles/market-wrap-tuesday-july-2-stocks-close-near-unchanged-mark-quiet-session-2013-07-02", "https://www.nasdaq.com/articles/immunotherapy-four-companies-verge-cancer-treatment-breakthroughs-2013-06-17", "https://www.nasdaq.com/articles/cldx-223-cohen-gains-big-2013-04-23", "https://www.nasdaq.com/articles/agenus-upcoming-mage-3-clinical-trial-results-will-have-major-impact-stock-2013-08-21", "https://www.nasdaq.com/articles/encouraging-data-presented-by-gilead-analyst-blog-2013-03-12", "https://www.nasdaq.com/articles/pharmacyclics-to-sell-shares-analyst-blog-2013-03-11", "https://www.nasdaq.com/articles/santarus-tops-focus-on-zegerid-analyst-blog-2013-03-11", "https://www.nasdaq.com/articles/arena-cuts-loss-misses-estimates-analyst-blog-2013-03-08", "https://www.nasdaq.com/articles/good-news-for-gileads-hiv-pipeline-analyst-blog-2013-03-07", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-7-2013-cnq-kr-bte-sfd-nav-jwa-fgp-cien-epl-prim-cmn-cldx", "https://www.nasdaq.com/articles/jazz-beats-eps-misses-sales-analyst-blog-2013-03-05", "https://www.nasdaq.com/articles/steve-cohen-increases-celldex-145-2013-04-06", "https://www.nasdaq.com/articles/pre-market-most-active-feb-6-2013-eln-qqq-bac-bbry-znga-nok-gsk-vmed-kb-sny-armh-cldx-2013", "https://www.nasdaq.com/articles/pre-market-most-active-dec-11-2012-aig-bac-htz-nok-fb-hca-gsk-siri-aapl-urbn-qqq-cldx-2012", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-10-2012-bam-jcp-har-cyd-hsft-cldx-hznp-scr-xin-urre-hska", "https://www.nasdaq.com/articles/pre-market-most-active-may-24-2012-bac-ppl-emc-ntap-hpq-mtge-cldx-ts-fb-mt-qqq-vod-2012-05", "https://www.nasdaq.com/articles/after-hours-most-active-may-23-2012-ntap-hpq-bac-blk-ifsia-qqq-f-cldx-kmi-pfe-eric-fb-2012", "https://www.nasdaq.com/articles/partner-or-not-partner-question-2011-03-10", "https://www.nasdaq.com/articles/amgen-celgene-and-novartis-fight-against-pancreatic-cancer-2010-10-26", "https://www.nasdaq.com/articles/celgenes-apremilast-encourages-analyst-blog-2013-03-04", "https://www.nasdaq.com/articles/monday-losers-delcath-cvs-caremark-and-coldwater-creek-2010-06-07", "https://www.nasdaq.com/articles/curtain-closes-asco-2010s-few-winners-2010-06-09"], "Content": []}